A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas (GBM), the most deadly form of brain tumors.
vVARDIS Announces $35 Million Financing with Global Healthcare Investor OrbiMed to Roll Out Curodont, an Innovative Drill-Free Treatment for Early Tooth Decay – Biotech Investments
EQS-News: vVardis AG / Key word(s): Financing vVARDIS Announces $35 Million Financing with Global Healthcare Investor OrbiMed to Roll Out Curodont, an Innovative Drill-Free Treatment